Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non–Small-Cell Lung Cancer
- 1 November 2015
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 16 (6) , e253-e258
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Negative Predictive Value of Positron Emission Tomography and Computed Tomography for Stage T1-2N0 Non–Small-Cell Lung Cancer: A Meta-AnalysisClinical Lung Cancer, 2012
- Diagnostic Performance of Integrated Positron Emission Tomography/Computed Tomography for Mediastinal Lymph Node Staging in Non-small Cell Lung Cancer: A Bivariate Systematic Review and Meta-AnalysisJournal of Thoracic Oncology, 2011
- PET-CT in the staging and treatment of non-small-cell lung cancerClinical and Translational Oncology, 2011
- Positron Emission Tomography/Computed Tomography in Lung Cancer Staging, Prognosis, and Assessment of Therapeutic ResponseJournal of Thoracic Imaging, 2011
- Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography☆European Journal of Cardio-Thoracic Surgery, 2009
- Mediastinoscopy might not be necessary in patients with non–small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3The Journal of Thoracic and Cardiovascular Surgery, 2008
- 18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense?Journal of Nuclear Medicine, 2007
- Test Performance of Positron Emission Tomography and Computed Tomography for Mediastinal Staging in Patients with Non–Small-Cell Lung CancerAnnals of Internal Medicine, 2003
- Invasive Staging of Non-small Cell Lung Cancer*Chest, 2003
- Regional Lymph Node Classification for Lung Cancer StagingChest, 1997